These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 77192

  • 1. Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the Aorta.
    Graham TP, Atwood GF, Boucek RJ.
    Cathet Cardiovasc Diagn; 1978; 4(1):97-102. PubMed ID: 77192
    [Abstract] [Full Text] [Related]

  • 2. Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.
    Heymann MA, Berman W, Rudolph AM, Whitman V.
    Circulation; 1979 Jan; 59(1):169-73. PubMed ID: 758109
    [Abstract] [Full Text] [Related]

  • 3. [Prostaglandin E1. Emergency therapy in infants with preductal coarctation of the aorta (author's transl)].
    Schöber JG, Kellner M.
    Monatsschr Kinderheilkd (1902); 1979 Oct; 127(10):617-20. PubMed ID: 492181
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease.
    Graham TP, Atwood GF, Boucek RJ.
    South Med J; 1978 Oct; 71(10):1238-41, 1246. PubMed ID: 81528
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
    Heymann MA, Clyman RI.
    Pharmacotherapy; 1982 Oct; 2(3):148-55. PubMed ID: 6763200
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of prostaglandin E1 in relieving obstruction in coarctation of the aorta without opening the ductus arteriosus.
    Liberman L, Gersony WM, Flynn PA, Lamberti JJ, Cooper RS, Stare TJ.
    Pediatr Cardiol; 2004 Oct; 25(1):49-52. PubMed ID: 15043008
    [Abstract] [Full Text] [Related]

  • 16. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
    Noah ML.
    Adv Prostaglandin Thromboxane Res; 1978 Oct; 4():355-62. PubMed ID: 347914
    [Abstract] [Full Text] [Related]

  • 17. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
    Olley PM, Coceani F, Bodach E.
    Circulation; 1976 Apr; 53(4):728-31. PubMed ID: 56243
    [Abstract] [Full Text] [Related]

  • 18. Indomethacin induced and prostaglandin relieved coarctation of the aorta in right aortic arch with left arterial duct: a case report.
    Golden-Plotnik S, Rosenberg HC, Altamirano-Diaz LA.
    Cardiol Young; 2017 Jul; 27(5):1026-1029. PubMed ID: 28260552
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Editorial: Nonsurgical palliation of congenital heart malformations.
    Olley PM.
    N Engl J Med; 1975 Jun 12; 292(24):1292-4. PubMed ID: 48193
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.